Surmodics Q4 Earnings and Revenues Beat Estimates, Margin Down [Yahoo! Finance]
Surmodics, Inc. (SRDX)
Last surmodics, inc. earnings: 4/29 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
surmodics.gcs-web.com/investor-overview
Company Research
Source: Yahoo! Finance
The metric beat the Zacks Consensus Estimate of a loss of 27 cents per share by 51.9%. GAAP loss per share for the quarter was 24 cents against the year-ago EPS of 47 cents . Revenues of $33.2 million rose 18.8% year over year. The figure surpassed the Zacks Consensus Estimate by 8.3%. The top line gained from solid year-over-year product sales growth from the Medical Device business, coupled with higher In Vitro Diagnostics sales. Surmodics operates via two reportable segments — Medical Device and IVD. Sales in the Medical Device segment totaled $25.8 million, up 22.4% from the year-ago level. Excluding SurVeil DCB license fee revenues, Medical Device revenues increased 20% to $23.9 million. Our model's projection for this segment's revenues was $23.8 million. The revenue growth in the Medical Device segment was primarily driven by product sales of $11.8 million, which rose 39% year over year, coupled with an increase in performance coating royalties and license fee reven
Show less
Read more
Impact Snapshot
Event Time:
SRDX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SRDX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SRDX alerts
High impacting Surmodics, Inc. news events
Weekly update
A roundup of the hottest topics
SRDX
News
- Surmodics, Inc. (NASDAQ: SRDX) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.MarketBeat
- SurModics (SRDX) is an Incredible Growth Stock: 3 Reasons Why [Yahoo! Finance]Yahoo! Finance
- Surmodics, Inc. (NASDAQ: SRDX) had its "hold" rating re-affirmed by analysts at Needham & Company LLC.MarketBeat
- Surmodics, Inc. (NASDAQ: SRDX) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.MarketBeat
- Surmodics Reports Fourth Quarter and Fiscal Year 2024 Financial ResultsBusiness Wire
SRDX
Earnings
- 5/1/24 - Beat
SRDX
Sec Filings
- 11/15/24 - Form SCHEDULE
- 11/14/24 - Form SC
- 11/6/24 - Form SC
- SRDX's page on the SEC website